This backbone of the U.S. health-care industry generates about 99% of its revenue domestically, insulating it from overseas pressure.
We’re initiating a position in this health-care stock with a $260 price target
– Advertisement –
U.S. crude oil posts biggest one-day drop since 2020 on U.S.-Iran ceasefire agreement 
Truce offers moment of respite for devastated Tehran 
